| Literature DB >> 10525537 |
D M Eckley1, S R Gill, K A Melkonian, J B Bingham, H V Goodson, J E Heuser, T A Schroer.
Abstract
The multisubunit protein, dynactin, is a critical component of the cytoplasmic dynein motor machinery. Dynactin contains two distinct structural domains: a projecting sidearm that interacts with dynein and an actin-like minifilament backbone that is thought to bind cargo. Here, we use biochemical, ultrastructural, and molecular cloning techniques to obtain a comprehensive picture of dynactin composition and structure. Treatment of purified dynactin with recombinant dynamitin yields two assemblies: the actin-related protein, Arp1, minifilament and the p150(Glued) sidearm. Both contain dynamitin. Treatment of dynactin with the chaotropic salt, potassium iodide, completely depolymerizes the Arp1 minifilament to reveal multiple protein complexes that contain the remaining dynactin subunits. The shoulder/sidearm complex contains p150(Glued), dynamitin, and p24 subunits and is ultrastructurally similar to dynactin's flexible projecting sidearm. The dynactin shoulder complex, which contains dynamitin and p24, is an elongated, flexible assembly that may link the shoulder/sidearm complex to the Arp1 minifilament. Pointed-end complex contains p62, p27, and p25 subunits, plus a novel actin-related protein, Arp11. p62, p27, and p25 contain predicted cargo-binding motifs, while the Arp11 sequence suggests a pointed-end capping activity. These isolated dynactin subdomains will be useful tools for further analysis of dynactin assembly and function.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10525537 PMCID: PMC2174220 DOI: 10.1083/jcb.147.2.307
Source DB: PubMed Journal: J Cell Biol ISSN: 0021-9525 Impact factor: 10.539
Figure 2Purification of dynactin shoulder/sidearm and shoulder complexes. (A) Elution profile of KI-treated dynactin run on a Superose12 column. Individual column fractions were analyzed on a Coomassie blue–stained SDS gel. Protein peaks A–E are bracketed. Dynactin subunits are indicated on the left (DM, dynamitin; CPα and CPβ, α and β subunits of capZ). Asterisks in peak C indicate the novel 43- and 25-kD species. (B) Peak A (dynactin shoulder/sidearm) was dialyzed to remove KI, and then sedimented into a 5–20% sucrose gradient. Individual gradient fractions were analyzed on a Coomassie blue–stained SDS gel. The load and positions of sedimentation standards (run in parallel) are indicated. Molecular weight markers are on the left. (C) Peak B (dynactin shoulder) was dialyzed, sedimented, and analyzed as above.
Figure 1In vitro disruption of dynactin by recombinant dynamitin. A mock-treated dynactin control (A and B) and dynactin preincubated with recombinant dynamitin (C and D) were sedimented into 5–20% sucrose gradients. Gradient fractions (L, load; P, pellet; fractions 1–10) were analyzed on Coomassie blue–stained SDS gels (A and C) or immunoblots (B and D) with antibodies against p150Glued (mAb 150B and actin). Dynactin subunits are indicated on the right (DM, dynamitin; CP, capZ). Molecular weight markers are on the left. (E) Fractions 6 and 7 from a sample similar to C were pooled, diluted, resedimented into a second 5–20% sucrose gradient, and then analyzed by SDS-PAGE as above.
Hydrodynamic Properties, Composition, and Predicted Mass of Dynactin Subcomplexes
| Dynactin subcomplex | S value | Stokes' radius | Predicted dimensions | Mr 1 | Mr 2 | Subunit | Mr | Stoichiometry* |
|---|---|---|---|---|---|---|---|---|
| nm | nm | Da | Da | Da | ||||
| p150 | 137,757 | 2 | ||||||
| Shoulder/sidearm | 9 | 10.7 | 21.4 × 1.2 | 396,550 | 386,373 | Dynamitin | 44,941 | 2 |
| p24 | 20,977 | 1 | ||||||
| Shoulder | 4.4 | 6.1 | 12.2 × 1.0 | 110,780 | 110,859 | Dynamitin | 44,941 | 2 |
| p24 | 20,977 | 1 | ||||||
| p62 | 53,086 | 1 | ||||||
| Pointed-end complex | 7 | 4.7 | 9.4 × 1.9 | 135,570 | 140,108 | Arp11 | 46,230 | 1 |
| p27 | 20,653 | 1 | ||||||
| p25 | 20,139 | 1 |
Subcomplex S values and diffusion coefficients were determined from multiple runs and compared with sucrose-gradient or gel-filtration standards run in parallel. Elution peaks were identified by A280 and confirmed by SDS-PAGE. Stokes radii were calculated from the diffusion coefficients. Subcomplex dimensions were predicted from the Perrin factor as described (Bloom et al. 1988). Molecular weights were calculated using the Svedberg equation (Mr 1, left column) or from molecular weights predicted from cloned cDNAs (Mr 2, right column). Mouse EST clones were used to predict the size of Arp11, p27, p25 (this study), and p24 (Pfister et al. 1998). The p62 mass was predicted from the cloned rat sequence (this study), p50 (human; Echeverri et al. 1996), and p150 (human; Tokito and Holzbaur 1998) masses were predicted from the published sequences.
* Subunit molar ratios in each subcomplex, estimated by scanning densitometry of a dilution series of each purified subcomplex, compared with a BSA standard.
Figure 3Ultrastructural comparison of intact dynactin (A), sucrose gradient-purified peak A molecules (shoulder/sidearm; B), and sucrose gradient-purified peak B molecules (shoulder; C). In the left-most dynactin image, the shoulder/sidearm structure and Arp1 minifilament domains are pseudocolored blue and pink for emphasis. One peak A molecule (isolated shoulder/sidearm) is colored blue accordingly. Bar, 40 nm.
Figure 4Purification and ultrastructural analysis of pointed-end complex. (A) Proteins in peak C were dialyzed, sedimented, and analyzed as described for shoulder/sidearm and shoulder complexes. Dynactin subunits are indicated on the right (CP denotes the α and β subunits of capZ). Molecular weight markers are on the left. (B) Purification of pointed-end complex by MonoS chromatography. The column load (L), flow through (FT), and individual column fractions are indicated. (C) Gallery of images of platinum replicas of sucrose gradient-purified peak C molecules (pointed-end complex). Bar, 40 nm.
Figure 5Predicted amino acid sequences of p62, p27, and p25. Tryptic peptide sequences obtained from each bovine protein are bold and underlined. (A) Rat p62 aligned with predicted sequences from fly (Drosophila melanogaster clone AC005447) and worm (C. elegans clone C26B2.4). The p62 sequence predicts RING finger–like metal-binding “knuckles” (CxxC or CxxH; indicated with asterisks). (B) Mouse p27 (AA073653) aligned with amino acid sequences deduced from fly (AC005705) and worm (Y54E10) genomic DNA sequences. (C) Mouse p25 (AA869597) aligned with amino acid sequences deduced from fly (AC002502) and worm (Y71F9AL) ESTs and genomic sequences.
Figure 6Comparison of Arp11 with actin and known Arps. (A) Comparison of mouse actin, Arp1, and Arp11 amino acid sequences. Mouse actin (AAA37164), Arp1(BAA24423), and Arp11 (this study) were aligned by CLUSTAL X. Actin residues implicated in calcium binding (Ca), nucleotide binding (N), myosin binding (M), or actin–actin contacts (a) are directly below labels. Residues identical to actin are shown in black, similar residues are shaded gray. Sequenced Arp11 tryptic peptides are underlined. Sites of insertions and deletions are indicated with red and green bars, respectively. (B) Arp11 changes presented in the context of actin crystal structure. Deletions are presented as red (open ribbons) and insertion points are labeled green (space-filling representation). Subdomains 1–4 are indicated. (C) Phylogenetic tree comparing actin and actin-related proteins from several species (Ac, Acanthamoeba castellanii; Ce, C. elegans; Dd, Dictyostelium discoideum; Dm, D. melanogaster; Dr, Danio rerio; Gg, Gallus gallus; Hs, Homo sapiens; Mm, Mus musculus; Nc, Neurospora crassa; Ysc, Saccharomyces cerevisiae; Ysp, Schizosaccharomyces pombe). Amino acid sequences were aligned by CLUSTAL X and plotted with Treeview PPC. Actin: 1: DmArp53D, P45891; 2: YscAct1p, BAA21512; 3: YspAct1p, P10989; 4: Hs alpha-actin, P02568; 5: Hs gamma-actin, P02571. Arp1: 6: YscArp1, P38696; 7: NcRopy-4, A54802; 8: CeArp1, Y53F4; 9: DmArp87C, P45889; 10: HsArp1, P42024; 11: MmArp1alpha, BAA24423. Arp2: 12: YscArp2, CAA98588; 13: CeArp2, P53489; 14: DmArp14D, P45888; 15: GgArp2, P53488; 16: HsArp2, NP_005713; 17: AcArp2, AAC46911; 18: DdArp2, AAC99776. Arp3: 19: YscArp3, P47117; 20: YspArp3, P32390; 21: NcArp3, P78712; 22: CeArp3, Y71F9A_294.A; 23: DmArp66B, P32392; 24: HsArp3, NP_005712; 25: DdArp3, P42528; 26: AcArp3, P53490. Arp4: 27: YscArp4, P80428; 28: YspC23D3.09, Q09849; 29: CeArp4, ZK616; 30: DmBAP55, AA949447; 31: HsActin-like gene, AB015906; 32: DrArp4, AI794230; 33: MmBaf53, AF041476; 34: HsBaf53a, ACTL6. Arp6: 35: Dm13E, P45890; 36: MmArp6, AA288832; 37: DrArp6, AI794429; 38: CeArp6, Q09443; 39: YscArp6, Q12509; 40: YspArp6, CAA19116. Arp5: 41: YscArp5, P53946; 42: MmArp5, AI550487; 43: DmArp5, AC006495. Other Arps: YscArp10, Q04549; NcRo-7 (M. Plamann, personal communication); MmArp11 (this study); HsArp11 (this study); YscArp8, Q12386; YscArp9, Q05123; YscArp100, CAA85175; YscArp7, Q12406.